Status: Recruiting
Preserving Geriatric Muscle With an Osteoporosis Medication
Our goal is to demonstrate efficacy of the novel agent Denosumab to improve or preserve muscle health, strength, mobility and function in frail older adults.
Participants needed: 155
Trial details
Phase: Phase 4Age: 65+Biological sex: AllType: InterventionalSponsor: Chrissy KistlerUpdated: Sep 23, 2026Locations: 1
Eligibility criteria
Not listed